News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CLSA Cuts ALI HEALTH's TP to HKD5.3, Rating Outperform
According to CLSA's report, ALI HEALTH (00241.HK) said at its 2HFY26 results outlook meeting that it maintained a solid revenue outlook but lowered its earnings expectations fo...
Reset
Send
The window will close in 5 seconds
<Research>CLSA Cuts ALI HEALTH's TP to HKD5.3, Rating Outperform
Close
Recommend
13
Positive
16
Negative
8
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

According to CLSA's report, ALI HEALTH (00241.HK)  -0.120 (-2.586%)    Short selling $125.18M; Ratio 32.989%   said at its 2HFY26 results outlook meeting that it maintained a solid revenue outlook but lowered its earnings expectations for investments in innovative drugs and AI technology.

As its previous investment in the personal prescription drug segment was lower than that of its peers, ALI HEALTH is also stepping up investment to catch up, which may affect its gross profit growth trajectory this year. Its AI investment is aligned with its parent company's broader AI strategy.

Related News G Sachs Cuts ALIBABA HEALTH (00241.HK) TP to HKD4.8, Rating Neutral; AI Investment to Weigh on Profits
CLSA has reduced its target price for ALI HEALTH from HKD6 to HKD5.3 but kept the Outperform rating unchanged.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-10 16:25.)

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.